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Previews
est is in characterizing the biological activities of theAn Early Taste
carbohydrates, which includes identifying receptors thatof Functional Glycomics bind the carbohydrates and enzymes that modify the
structures.
The development of carbohydrate microarrays has
the potential to vastly accelerate the biochemical char-
Recent advances in the synthesis of carbohydrates acterization of carbohydrates. The microarrays are
and in microarrays for profiling biochemical activities clearly inspired by the successes of the analogous gene
have set the stage for rapid advances in understanding chips and protein chips, which allow the identification
the biological roles for oligosaccharides. An early ex- of biochemical interactions from thousands of possibili-
ample by Seeberger and colleagues illustrates the use ties. The first carbohydrate arrays, reported in 2002,
of these tools in HIV infection [1]. emphasized the preparation of the arrays and their utility
in model experiments [5–7]. Since that time, several re-
Following DNA and protein, carbohydrates are gaining ports have disclosed approaches to carbohydrate
recognition as a third class of biopolymer that plays an arrays that differ in the source of the oligosaccharides
important role in a broad range of biological activities (natural or synthetic), the chemistries used for immobili-
[2]. The development of DNA and protein science—and zation of the structure, and the control over the densi-
of the current emphasis on genomics and proteomics— ties, steric environment, and orientation of ligands.
can be traced to important advances in both the charac- These reports have set the stage for studies that use
terization and the synthesis of these biopolymers. In- the arrays to discover novel interactions in glyobiology.
deed, the development of rapid and reliable sequencing The paper in this issue of Chemistry & Biology by
methods, together with synthetic protocols for the prep- Seeberger, O’Keefe, and coworkers makes an important
aration of oligonucleotides and peptides on solid-phase, advance by applying the microarrays to a biological
has made studies of protein and DNA biochemistry rou- problem of high interest: the gp120-mediated infection
tine. The study of carbohydrates, by contrast, is only of HIV. In so doing, the work shows the value of the
now benefiting from analogous developments. arrays in biomedical research and also points to oppor-
On the synthesis front, two approaches are providing tunities for further developments in carbohydrate arrays.
access to complex oligosaccharides. Peter Seeberger’s The authors investigated the role of oligosaccharides
group at the ETH has pioneered chemical methods for in the infectious process of HIV. The viral surface pre-
the automated synthesis of complex carbohydrates us- sents a glycoprotein, gp120, which plays a prominent
ing a synthesizer analogous to those used for DNA and role in penetration of the virus into cells of the immune
peptides [3]. Chi-Huey Wong’s laboratory at the Scripps system. gp120-associated molecules interact with CD4
Research Institute has harnessed the enzymes that are proteins and chemokine receptors on T lymphocytes,
involved in glycosylation to provide for biochemical syn- macrophages, and dendritic cells to initiate internaliza-
thesis of these molecules [4]. Taken together, these tion of HIV by the host cell. These interactions depend
groups have provided routes to structures that were on the N-linked high-mannose oligosaccharides present
previously available only through many years of syn- on the protein. Hence, an understanding of the role of
thetic effort, and have laid the groundwork for further the carbohydrates from gp120 in mediating infection
developments that will make the preparation of complex could have important implications for the development
oligosaccharides routine. of vaccines for treatment and the identification of protein
On the analysis front, glycobiology faces a more diffi- targets for small molecule drug discovery.
cult challenge than did protein and DNA research. First, Seeberger and colleagues used microarrays present-
oligosaccharides are often branched structures, compli- ing oligosaccharides and glycoproteins to characterize
cating the task of structural characterization. Second, the binding specificities of four gp120 binding proteins.
the carbohydrates are usually present as a heteroge- These proteins included 2G12, a human monoclonal an-
neous population of related structures. Hence, it can be tibody, DC-SIGN, a dendritic cell lectin, and two pro-
difficult to define the substructure of a complex carbohy- teins, cyanovirin and scytovirin from cyanobacteria that
drate that is the biologically relevant motif. And finally, have been found to possess anti-HIV effects. Arrays
there is no single enzymatic machinery for preparing presenting gp120, gp41 (another HIV-surface glycopro-
carbohydrates, dimming the prospect for identification tein), and several other synthetic glycoproteins were
of a “glycomic” code that can aid the prediction of car- used in experiments that applied fluorescently labeled
bohydrate structures from genetic information. proteins in order to identify protein-glycoprotein interac-
Given these challenges, the practice of characterizing tions. The aim of these studies was to identify the carbo-
carbohydrates proceeds along two lines. Structural hydrate motifs that mediated the protein binding activi-
characterization follows the methods of chemical analy- ties and to mechanistically distinguish the protein
sis, which begin with tedious purification of carbohy- binding activities.
drate ligands and use of mass spectrometry, nuclear Among the results of these binding experiments was
magnetic resonance spectroscopy, and other analytical the finding that both DC-SIGN and 2G12 bind to the
gp41 molecule. The results with 2G12 raise the questionmethods to characterize the structures. The other inter-
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of whether 2G12’s in vivo efficacy is due to its interac- uses self-assembled monolayers that present carbohy-
tions with gp120 alone or binding the high-mannose drates and has been shown to identify enzyme and pro-
oligosaccharides present on both gp120 and gp41—an tein binding activities [9].
important question for designing synthetic vaccines. A second objective is to carry out biochemical analy-
The authors also used the arrays to investigate the inter- sis of the interactions of carbohydrates with proteins
actions of multiple proteins with gp120. This effort lead and enzymes directly on a chip. The benefits of a chip-
to the unexpected finding that pretreatment of gp120 based format include the use of small amounts of reagents
with cyanovirin did not affect binding of CD4 to gp120, and rapid structure-activity profiling of the interaction
but when gp120 was first treated with CD4, addition of for a family of carbohydrate analogs. These biochemical
cyanovirin resulted in displacement of the CD4. Further, assays require that the microarrays provide quantitative
when CD4 was prebound to nonglycosylated gp120 information on activities, and that the data agree with
(p120), cyanovirin did not displace CD4. The authors the results of conventional solution-phase assays. There
suggest a model wherein treatment of CD4-bound are now surface chemistries that provide good control
gp120 with cyanovirin induces conformational changes over the orientations, densities, and environments of
in gp120 that disrupt existing gp120-CD4 interactions. immobilized ligands and that also prevent nonspecific
This intriguing finding may also be explained by different interactions with proteins. For carbohydrates, the con-
kinetic courses for binding that depend on the order of trol over density of ligand is especially important, since
protein addition. In either event, the microarray-based many proteins that bind these ligands do so in a polyva-
experiments are significant because they identify unan- lent manner and can show dramatic differences in bind-
ticipated mechanisms for understanding CVN’s inhibi- ing affinities and even specificities as the density is
tory effects and in turn give rise to hypotheses that can varied [10, 11].
be tested directly. The field of glycobiology has benefited greatly from
The authors next used a carbohydrate array to define advances in chemical tools—in both synthesis and anal-
the core motif that is recognized by the antibody. This ysis—over the past five years. With the paper by See-
information is vital to designing vaccines that give im- berger and colleagues in this issue, these tools have
mune responses that mimic the 2G12 antibody. The been combined to better understand the role of the
array comprised a high-mannose nona-saccharide and gp120 glycoprotein in HIV infection. We should expect
several smaller oligosaccharides that are substructures that these approaches will be applied to several other
of this parent. An analysis of the binding profile of 2G12 glycobiology problems over the next period.
to this array revealed that the antigenic fragment com-
prised the disaccharide motif Man1-2Man. Further
studies established that the binding of antibody did not Milan Mrksich
depend on the polypeptide backbone structure. The The University of Chicago
manuscript also describes analogous experiments to Department of Chemistry
understand the binding profiles of other proteins, includ- 5735 South Ellis Avenue
ing scytovirin, a novel HIV-inactivating protein. Taken Chicago, Illinois 60637
together, these examples establish that carbohydrate
arrays can be used to rapidly profile the binding specific- Selected Reading
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